Back to GLENMEDE TRUST CO NA GLENMEDE TRUST CO NA

TGTXTGTX

Showing 0 of 6 quarters

Position history for GLENMEDE TRUST CO NAGLENMEDE TRUST CO NA's holdings in TG THERAPEUTICS INC

No. Glenmede Trust exited its TGTX (TG Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 15,562 shares worth $184,098. Glenmede Trust first reported TGTX in Q4 2020 and held it in 4 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used